As the outbreak of COVID-19 caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) first broke out in Hubei Province, China, at the end of 2019. It has brought …

Pulmonary fibrosis is characterized by extracellular deposition in the lung primarily collagen
but also other ECM molecules. The primary cell type responsible for this is the myofibroblast …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), like other viruses, can
induce proliferation of myofibroblasts and even lead to fibrosis in the lung. Epithelial …

The pathogenetic mechanism of post-Covid-19 pulmonary fibrosis is currently a topic of
intense research interest, but still largely unexplored. The aim of this work was to carry out a …

SARS-CoV-2 infection is a significant health concern that needs to be addressed not only
during the initial phase of infection but also after hospitalization. This is the consequence of …

Acute respiratory distress syndrome (ARDS) followed by repair with lung remodeling is
observed in COVID-19. These findings can lead to pulmonary terminal fibrosis, a form of …

Pulmonary fibrosis is a sequelae of Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) infection that currently lacks effective preventative or therapeutic measures …

Pulmonary fibrosis (PF) is a feared outcome of many pulmonary diseases which results in a
reduction in lung compliance and capacity. The development of PF is relatively rare, but it …

While the coronavirus disease 19 (COVID-19) pandemic has transformed the medical and
scientific communites since it was first reported in late 2019, we are only beginning to …

The COVID-19 pandemic rapidly became a worldwide healthcare emergency affecting
millions of people, with poor outcomes for patients with chronic conditions and enormous …